Daniel Burgess, BSc, FRQA, is the Chief Compliance Officer of Pharm-Olam International bringing over 25 years of experience in the critical areas of quality assurance, quality control, auditing, training, data privacy and compliance. His experience includes progressive Quality leadership roles within several leading pharmaceutical industry organizations including Ipsen, Novartis, Alexion, Thermo Fisher Scientific and Pfizer.
Mr. Burgess holds a bachelor’s degree from the University of South Wales, UK and further qualifications in ISO, audit and instructional design. A graduate from the initial cohort of the RQA Diploma in Research Quality Assurance, he is recognized by his peers as a Fellow in Research Quality Assurance. He is a speaker and tutor for a number of international quality associations and serves on the editorial board of LSCU (Life Science Compliance Update). An advocate of continuous improvement and transparency, Mr. Burgess is regarded as an expert and thought leader in practical process improvement and achievement through visual measurement.